Medicalsystem Biotechnology (300439.SZ) obtained two medical device registration certificates.
Meikang Biotechnology (300439.SZ) announced that the company recently obtained the "Medical Device Registration Certificate (In vitro diagnostic reagent)" issued by the National Medical Products Administration and Zhejiang Provincial Medical Products Administration, including: Hepatitis B virus e antibody detection reagent kit (Chemiluminescent microparticle immunoassay), Golgi protein 73 detection reagent kit (Chemiluminescent microparticle immunoassay).
Medicalsystem Biotechnology (300439.SZ) announced that the company has recently obtained the "Medical Device Registration Certificate (In Vitro Diagnostic Reagents)" issued by the National Medical Products Administration and the Zhejiang Provincial Medical Products Administration, which includes: Hepatitis B virus e-antibody detection kit (Chemiluminescence Microparticle Immunoassay) and Golgi body protein 73 detection kit (Chemiluminescence Microparticle Immunoassay).
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
